ArticleJournal of hand surgery global online2026
Rising Use of Ultrasound-Guided Carpal Tunnel Injections: National Trends, Drivers of Utilization, and Outcomes.
Article in Journal of hand surgery global online, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Endoscopic Versus Open Carpal Tunnel Release in Obese and Nonobese Patients.Journal of hand surgery global online · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Carpal tunnel syndrome may be considered for carpal tunnel injection (CTI). Ultrasound (US) guidance has been proposed to improve CTI accuracy, but the trend across the years, factors associated with utilization, and outcomes are not well characterized. Methods: Patients undergoing CTI with or without US guidance were identified from the PearlDiver M170 database (2010-2022). The trend of US-guided CTI was assessed by linear regression. Patient demographics and provider specialty were compared by multivariable analyses. Two-year survival to repeat injection and carpal tunnel release (CTR) were assessed by univariable and multivariable analyses. Results: Of 478,645 patients undergoing CTIs, US guidance was used for 62,525 (13.1%). Over the years, this utilization increased from 3.6% to 17.1% (β = 0.97 %/year).Factors statistically significantly associated with US utilization were region (relative to South, Northeast: odds ratio [OR] = 1.62, West: OR = 1.08, Midwest: OR=1.06), Medicare insurance (relative to commercial, OR = 1.07), higher Elixhauser Comorbidity Index (OR = 1.04), and younger age (OR = 1.03 per decade). Relative to hand surgeons, lower utilization was noted for other orthopedic surgeons (OR = 0.71) and plastic surgeons (OR = 0.04), and higher utilization was noted for multiple specialties, led by physical medicine and rehabilitation (OR = 9.36) and anesthesia (OR = 8.34).US guidance was associated with higher incidence of repeat CTI (15.0% vs 12.9%, OR = 1.37). In unadjusted analyses, CTR incidence was lower following US-guided CTI (31.1% vs 37.8%). However, when controlling for provider specialty, the direction of this association reversed, with greater odds of CTR following US-guided CTI (OR=1.21). Conclusions: Utilization of US-guided CTI increased from 2010 to 2022. The association with nonclinical drivers suggests lack of therapeutic consensus. Although unadjusted analyses revealed lower CTR incidence following US-guided CTI, the reversal of this association after controlling for provider specialty highlights the influence of provider-level variability and room for algorithm-driven care pathways. Type of study/level of evidence: Retrospective cohort, therapeutic IIc.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.